PHILADELPHIA — A vaccine for pneumonia and meningitis that is routinely given to babies has exceeded expectations. Not only is it effective in preventing pneumococcal infections, it has reduced those illnesses caused by antibiotic-resistant bacteria by nearly two-thirds in the four years since it was approved for use.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.